Clinical Trial

Comparative Effects of Cadence Training vs Elliptical Training in Cricketers

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 27, 2026 (before its estimated June 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
Patellofemoral pain syndrome (PFP) is a frequent cause of anterior knee pain in sportspeople, especially those playing some sport that involves high-impact and rapid changes of direction and frequent lower-limb loading such as in cricket. The stress of patella is augmented by the activities and results in pain and functional performance decline. Strategies of rehabilitation which minimize the stress on the knee joints and maximizes strength, power and endurance are required. Elliptical training offers a low-impact aerobic alternative with negligible patellofemoral loading whereas cadence training highlights a controlled movement frequency and ideal movement patterns which may alleviate stress on the joints and increase neuromuscular coordination. To compare the effects of cadence training versus elliptical training on pain, power, and endurance among cricketers with patellofemoral pain syndrome. It was a randomized clinical trial involving 48 cricketers aged between 18 35 years with positive patellofemoral compression test and at least 2 3 years of playing experience. The individuals were randomly divided into two groups (n = 24 each) and Group A was allocated to the cadence training and Group B to elliptical training. The sessions were conducted over six weeks with each session taking 45 minutes three times a week. The pre- and post-intervention measures were Vertical Jump Test (power), Wall Sit Test (endurance), and Numeric Pain Rating Scale. The paired, Wilcoxon, Mann Whitney and independent t tests were used to analyze the data and compare the within and between-group differences.
Trial Details
NCT Number NCT07438587
Lead Sponsor Riphah International University
Conditions Sports Physical Therapy
Enrollment 48 participants
Start Date 2026-03-15
Primary Completion 2026-06-01 (estimated)
Study Completion 2026-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-02-27